Despite the ubiquity and importance of HIF-1 response and our knowledge about the variation in the global transcriptional response to hypoxia among different cell types, little is known about gene expression signatures that might relate to melanoma development and response to treatments. This evidence concerns the gene HIF1A and melanoma.